Immunity Pharma Ltd. Company

Immunity Pharma Ltd. (IPL) develops therapies for neuro-degenerative diseases with an initial focus on Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
Industry: Loss of Proteostasis
Headquarters: Israel
Visit Website
info@immunitypharma.com <info@immunitypharma.com>;
Register and Claim Ownership